Last $0.79 USD
Change Today -0.03 / -3.66%
Volume 79.4K
RGDX On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas A. Bologna

Chairman and Chief Executive Officer, Response Genetics, Inc
AgeTotal Calculated CompensationThis person is connected to 14 board members in 3 different organizations across 6 different industries.

See Board Relationships
66$1,307,194
As of Fiscal Year 2013

Background*

Mr. Thomas A. Bologna, also known as Tom, has been the Chairman and Chief Executive Officer of Response Genetics, Inc., since December 21, 2011. Mr. Bologna served as the Chief Executive Officer and President of Orchid Cellmark Inc. since April 25, 2006. He served as the President and Chief Executive Officer of Orchid Cellmark Ltd., a subsidiary of Orchid Cellmark Inc. He served as President and Chief Executive Officer of Quorex Pharmaceuticals, Inc. since September ...

Read Full Background

Corporate Headquarters*

1640 Marengo Street
Los Angeles, California 90033

United States

Phone: 323-224-3900
Fax: 323-224-3096

Board Members Memberships*

1997-N/A
Former Chairman of the Board, Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer
2004-N/A
Former Chief Executive Officer, President and Director
2005-N/A
Former Director
2006-N/A
Former Director
2010-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2011-Present
Chairman and Chief Executive Officer
2011-N/A
Director
2012-Present
Director, Member of Audit Committee, Member of Remuneration Committee and Member of Nominating & Corporate Governance Committee

Education*

BS
New York University
MBA
New York University

Other Affiliations*

Annual Compensation*

Salary$576,654
Bonus$323,600
Total Annual Compensation$900,254

Stock Options*

All Other Compensation$163,154
Exercisable Options1,002,173
Unexercisable Options329,827
Total Number of Options1,332,000

Total Compensation*

Total Annual Cash Compensation$1,063,408
Total Short Term Compensation$900,254
Other Long Term Compensation$163,154
Total Calculated Compensation$1,307,194
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGDX:US $0.79 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$649.0K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$380.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESPONSE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.